GoldBamboo.com - Knowledge is strong medicine
  

Race-based pill puts marketing to the test - News


  Not Signed In - Sign In / Register






Race-based pill puts marketing to the test

Tue, 11 Apr 2006 10:18 PM EST

...

Boston Medical Center nurse practitioner Diane Gauthier, left, speaks with Vernon S. Truell, a patient who has taken BiDil, at the medical center in Boston, Monday, March 27, 2006. Eight months after BiDil became the first drug approved for use in a specific racial group, NitroMed Inc. concedes initial sales of its first commercial product are disappointing. (AP Photo/Chitose Suzuki)In the nine months since the heart drug BiDil became the first medication approved for a specific racial group, its manufacturer has been charting new territory in marketing.


...

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource

August 30, 2008



Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.